Selective serotonin reuptake inhibitors and risk of cerebral bleeding

Stroke

Volumn 45, Issue 7, 2014, Pages 1917-1918

  Hankey, Graeme J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Editorial; intracerebral hemorrhage; medication; risk

Indexed keywords

CLOMIPRAMINE; DULOXETINE; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ALCOHOL ABUSE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DEPRESSION; DIABETES MELLITUS; EDITORIAL; FATIGUE; FRACTURE; HEART INFARCTION; HUMAN; HYPONATREMIA; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEIZURE; SMOKING; UPPER GASTROINTESTINAL BLEEDING; WHITE MATTER LESION;

EDITORIAL; INTRACEREBRAL HEMORRHAGE; MEDICATION; RISK;

BRAIN; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS;

EID: 84903792311     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005844     Document Type: Editorial

References (13)

1. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: A systematic review of observational studies. Stroke. 2005;36: 1330-1340. (Pubitemid 40798764)
2. El Husseini N, Goldstein LB, Peterson ED, Zhao X, Pan W, Olson DM, et al. Depression and antidepressant use after stroke and transient ischemic attack. Stroke. 2012;43: 1609-1616.
3. Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database of Syst Rev 2012;11:CD009286.
4. Mead GE, Dennis M, Lundström E, Murray V, Hackett M, Hankey GJ. Letter by Mead et al regarding article, "Selective serotonin reuptake inhibitors for stroke: more trials are needed". Stroke. 2013;44: e40-e41.
5. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.
6. Hackam DG, Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: A meta-analysis. Neurology. 2012;79: 1862-1865.
7. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: A systematic review and meta-analysis. Lancet Neurol. 2010;9: 167-176.
8. de Abajo FJ. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging. 2011;28: 345-367.
9. Hill AB. The environment and disease: Association or causation? Proc R Soc Med. 1965;58: 295-300.
10. Tang WK, Chen Y, Liang H, Chu WC, Mok VC, Ungvari GS, et al. Cerebral microbleeds as a predictor of 1-year outcome of poststroke depression. Stroke. 2014;45: 77-81.
11. Tang WK, Liu XX, Chen YK, Abrigo J, Chu WC, Mok VC, et al. Cerebral microbleeds and fatigue in stroke. Eur Neurol. 2014;71: 213-216.
12. Aarts N, Akoudad S, Noordam R, Hofman A, Arfan Ikram M, Stricker BH, et al. Inhibition of serotonin reuptake by antidepressants and cerebral microbleeds in the general population. Stroke. 2014:45: 1951-1957.
13. Löppönen P, Tetri S, Juvela S, Huhtakangas J, Saloheimo P, Bode MK, et al. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: A population-based study [published online ahead of print February 7, 2014]. J Neurosurg. doi: 10.3171/2013.12.JNS131898. http://thejns.org/ doi/pdf/10.3171/2013.12.JNS131898. Accessed April 30, 2014.